Skip to content

Self-Management and Resilience Trajectories in African American Adults With Hypertension

Self-Management and Resilience Trajectories in African American Adults With Hypertension

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05308914
Enrollment
125
Registered
2022-04-04
Start date
2022-03-01
Completion date
2025-03-21
Last updated
2026-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Compliance, Medication, Compliance, Patient, Compliance, Treatment, Hypertension, Quality of Life, Self-Management

Keywords

Hypertension, Self-Management, Resilience

Brief summary

Hypertension (HTN) rates have increased worldwide, but the most significant increase in the incidence of morbidity and mortality has been in African Americans (AA) (43% vs 27% for other U.S. population groups). Despite evidence of positive benefits from lifestyle modification (healthy diet, reduced sodium intake, increased physical activity, smoking cessation) and prescribed antihypertensive therapy (AHT) many AA with HTN do not adhere to their treatment regimens. Consistent, effective lifelong self-management is required to sustain optimal BP control and thus reduce morbidity and mortality. Self-managing HTN to a blood pressure (BP) \<130/80 mm Hg presents challenges such as juggling multiple medications and health care providers, dealing with complex recommendations and treatment regimens, and coping with negative emotional states. Few studies have examined the biopsychosocial mechanisms that foster effective HTN self-management and resilience among AA living with HTN. Understanding the mechanisms that influence HTN self-management and resilience in AA holds the promise of new modifiable targets for behavior-change interventions. This study explores the relationship among resilience precursors on hypertension (HTN) self-management behaviors, stress response, and the effects that these relationships have on health outcomes-health-related quality of life (HRQOL) and blood pressure (BP) in African Americans (AA) with HTN over a 6-month period.

Detailed description

This study identifies profiles of self-management and the resilience trajectories in AA with HTN can lead to culturally appropriate, patient-centered interventions that improve their HTN self-management, quality of life, and long-term compliance. This study aims to: 1. Assess the association among resilience precursors (dispositional optimism and resilience, emotion regulation); stress response (physiological: cortisol, interleukins \[IL-6\] and psychological: depression cognitions, perceived stress); hypertension self management behaviors (self-efficacy for chronic disease management, medication adherence to antihypertensives); and health outcomes (HQROL and BP) in AA with HTN at baseline and months 3 and 6. 2. Determine if stress response mediates the relationship between resilience precursors and health outcomes over time when controlling for risk regulators. 3. Determine if self-management behaviors mediates the relationship between resilience precursors and health outcomes over time when controlling for risk regulators. 4. Identify resilience trajectory patterns and factors that influence HTN self-management behaviors over time.

Interventions

None listed

Sponsors

Case Western Reserve University
Lead SponsorOTHER
University Hospitals Cleveland Medical Center
CollaboratorOTHER

Study design

Observational model
OTHER
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
25 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Self-identify as African American * 25 years of age or older * Diagnosed with hypertension and prescribed one antihypertensive medication * BP \>130/80 mmHg * Have at least one additional chronic health conditions * Able to read/understand English

Exclusion criteria

* Unable to give informed consent or judged to have impaired cognitive ability or severe memory * Have experienced a major CVD event or procedure (e.g., myocardial infarction, stroke, heart surgery) within the past year

Design outcomes

Primary

MeasureTime frameDescription
Systolic Blood PressureBaseline - 6 monthsMeasure of participants' in clinic blood pressure (average of three blood pressure readings). Defined as the Number (%) of participants who achieved Systolic Blood Pressure \< 130mmHg at Baseline and 6 months.
Diastolic Blood PressureBaseline - 6 monthsMeasure of participants' in clinic blood pressure (average of three blood pressure readings).
PROMIS Global Health-10 [Health-related Quality of Life]Baseline - 6 monthsPROMIS Global Health-10 is divided into 2 separate components: Global Physical Health and Global Mental Health. The possible score ranges from 0 to 20 points in each component, where 0 points represent the patient's most severe state of physical and/or mental health, while 20 points represent the best possible state of physical and/or mental health. A higher score indicates better quality in domains of physical and/or mental health and functioning.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORCarolyn Still, PhD

Case Western Reserve University, School of Nursing

Participant flow

Recruitment details

Participants were recruited from clinics affiliated with University Hospitals Cleveland Medical Center (UHCMC), community centers, clinician referrals, and targeted advertisements from 2022 to 2024.

Baseline characteristics

Characteristic
Age, Customized
Age
62.66 Years
STANDARD_DEVIATION 12.32
Education Level
College degree
43 Participants
Education Level
Graduated from high school
21 Participants
Education Level
Greater than high school/Trade School
51 Participants
Education Level
Less than high school
9 Participants
Employment status
Employed
60 Participants
Employment status
No reports on employment status
7 Participants
Employment status
Not employed
57 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
124 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Insured
Medicaid
25 Participants
Insured
Medicare
29 Participants
Insured
More than one insurance
23 Participants
Insured
Private
43 Participants
Insured
Veteran Benefits
4 Participants
Marital Status
Married
38 Participants
Marital Status
No reports on marital status
1 Participants
Marital Status
Single
85 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
124 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
0 Participants
Sex: Female, Male
Female
83 Participants
Sex: Female, Male
Male
41 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 125
other
Total, other adverse events
13 / 125
serious
Total, serious adverse events
0 / 125

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 16, 2026